Furosemide* (Furosemide) — Medicare Part D spending
Multiple manufacturers (26) · Rank #301 by total Part D spend · CMS data year 2023
Medicare Part D spent $144,867,532 on Furosemide* (Furosemide) in 2023, the #301 drug by total Part D spending out of 3,598 drugs. That worked out to about $0.0979 per dosage unit, $6 per claim and $26 per beneficiary, across 23,026,214 claims for 5,640,922 beneficiaries. Average spending per dosage unit rose +6.7% from 2022. These are aggregate Medicare program figures (gross drug cost), not the price you pay.
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
Furosemide* (Furosemide) spending at a glance (2023)
| Metric | Furosemide* (Furosemide) |
|---|---|
| Total Part D spending (2023) | $144,867,532 |
| Total spending (2022) | $139,703,052 |
| Year-over-year change in total spending | +3.7% |
| Average spending per dosage unit (2023) | $0.0979 |
| Change in spend per dosage unit (YoY) | +6.7% |
| Avg annual change per dosage unit (2019-2023 CAGR) | -0.7% |
| Average spending per claim (2023) | $6 |
| Average spending per beneficiary (2023) | $26 |
| Total claims (2023) | 23,026,214 |
| Beneficiaries (2023) | 5,640,922 |
| Total dosage units (2023) | 1,502,674,963 |
| Manufacturer(s) | Multiple manufacturers (26) |
| National rank by total spend (of 3,598 drugs) | #301 |
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
2022 vs 2023
| Metric | 2022 | 2023 | Change |
|---|---|---|---|
| Total spending | $139,703,052 | $144,867,532 | +3.7% |
| Avg spend per dosage unit | $0.0918 | $0.0979 | +6.7% |
| Avg spend per claim | $6 | $6 | — |
| Avg spend per beneficiary | $25 | $26 | — |
| Total claims | 22,880,053 | 23,026,214 | — |
| Beneficiaries | 5,596,682 | 5,640,922 | — |
How Furosemide* compares with nearby drugs
Drugs with total Part D spending closest to Furosemide* (Furosemide):
| Drug (rank) | Total spend 2023 | Per dosage unit | Per-unit YoY |
|---|---|---|---|
| Furosemide* (Furosemide) (this drug, #301) | $144,867,532 | $0.0979 | +6.7% |
| Firdapse (Amifampridine Phosphate) (#299) | $146,333,212 | $227.71 | +7.9% |
| Rezurock (Belumosudil Mesylate) (#300) | $146,107,630 | $585.19 | +7.4% |
| Paliperidone ER (Paliperidone) (#302) | $143,466,904 | $11.16 | -11.8% |
| Aptiom (Eslicarbazepine Acetate) (#303) | $142,014,028 | $42.46 | +7.8% |
| Divalproex Sodium (#304) | $141,849,481 | $0.45 | -6.4% |
Frequently asked questions
How much does Medicare Part D spend on Furosemide*?
Medicare Part D spent $144,867,532 on Furosemide* (Furosemide) in 2023 (the latest CMS data year), across 23,026,214 claims for 5,640,922 beneficiaries. That ranks #301 of 3,598 drugs by total Part D spending. This is gross drug cost (Medicare, plan and beneficiary payments combined), not the price you personally pay.
What is the average spending per dosage unit for Furosemide*?
In 2023, the weighted average Medicare Part D spending per dosage unit for Furosemide* (Furosemide) was $0.0979. Compared with 2022 it rose +6.7%. A "dosage unit" is one pill, tablet, milliliter or other billing unit, so this is not the price of a prescription.
Who makes Furosemide*?
CMS attributes Furosemide* (Furosemide) to Multiple manufacturers (26) in the 2023 Part D spending file. Average spending per claim was $6 and per beneficiary $26.
Is the Furosemide* figure the price I pay?
No. These are aggregate Medicare Part D program figures (total gross drug cost and averages across all claims), published by CMS for transparency. Your out-of-pocket cost depends on your plan, formulary, deductible and coverage phase. Always check your plan and talk to your pharmacist or doctor.
Keep exploring
Source & what this means
Figures are from the CMS Medicare Part D Spending by Drug dataset (data year 2023, US public domain). "Total spending" is the gross drug cost — Medicare, plan and beneficiary payments combined — for Part D claims; it is not a list price, a negotiated price, or what any individual pays. Spending per dosage unit is volume-weighted across formulations. This is general public-spending information, not medical or pricing advice. Your own cost depends on your plan, deductible and coverage phase — verify with your Part D plan and a pharmacist. Data as of June 2026. See our methodology and disclaimer.
Last updated: 2026-06-20